Product NDC: | 25021-656 |
Proprietary Name: | Midazolam |
Non Proprietary Name: | midazolam hydrochloride |
Active Ingredient(s): | 5 mg/mL & nbsp; midazolam hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25021-656 |
Labeler Name: | Sagent Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090315 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120319 |
Package NDC: | 25021-656-01 |
Package Description: | 10 VIAL in 1 CARTON (25021-656-01) > 1 mL in 1 VIAL |
NDC Code | 25021-656-01 |
Proprietary Name | Midazolam |
Package Description | 10 VIAL in 1 CARTON (25021-656-01) > 1 mL in 1 VIAL |
Product NDC | 25021-656 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | midazolam hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20120319 |
Marketing Category Name | ANDA |
Labeler Name | Sagent Pharmaceuticals |
Substance Name | MIDAZOLAM HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |